pharmaphorum

JUNE 1, 2021

Two different types of microtaggants are now available, one produced from non-biologic DNA and the other from silica: DNA microtaggants. DNA is robust and easy to detect and because it is possible to produce different versions of the same DNA molecule, it can be made regional, product, or company-specific. Reduce wastage.

Medicine 52

Medicine DNA Pharmacy Production 52

XTalks

MARCH 1, 2024

Recently, the development of high-throughput DNA testing methods has made the precise identification of high-risk HPV strains possible. High-Precision Molecular Testing The shift towards molecular testing methods that can detect the presence of HPV DNA in cervical cells has been an important development.

Vaccination 52

Vaccination Vaccine Life Science FDA Approval 52

XTalks

FEBRUARY 4, 2021

Bernard, executive vice president for research and chief research officer at Vanderbilt University Medical Center, shared his experience in helping set up a DNA and clinical data resource called BioVU. The project began in 2004, in the early days of biobanking for DNA, says Dr. Bernard, and has grown tremendously since.

Research 98

Research Biobanking Drugs Genome 98

XTalks

FEBRUARY 3, 2021

Johnson & Johnson’s single-shot DNA vaccine candidate was shown to have an overall effectiveness of 66 percent in preventing moderate to severe COVID-19. Johnson & Johnson’s DNA Vaccine. The DNA vaccine was created using Janssen’s AdVac technology platform that is designed for rapid vaccine development.

Vaccination 103

Vaccination Vaccine Trials Protein 103

The Pharma Data

NOVEMBER 24, 2020

The Notice of Compliance was granted under priority review and marks the first Health Canada approval of a PARP inhibitor in prostate cancer. “Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer.” MISSISSAUGA, ON , Nov. 6 Annala, Matti et al.

Gene 52

Gene Hormones DNA Medicine 52

Cloudbyz

MARCH 6, 2024

Unlike traditional small molecule drugs, which are chemically synthesized, biologics are produced through complex biotechnological processes, often involving recombinant DNA technology. Longer Lasting Effects: Many biologics have prolonged therapeutic effects, allowing for less frequent dosing regimens and improved patient compliance.

Gene 73

Gene Immune Response Manufacturing Gene Therapy 73

Drug Discovery World

MAY 16, 2023

He continues: “ISCT has also embraced the opportunity to foster collaboration among the CGT community to enable successful process development and regulatory compliance. This issue has become a key focus for the ISCT, and we have been working to identify and develop initiatives to help alleviate these shortages.”

Gene Therapy 52

Gene Therapy Gene Manufacturing Marketing 52

Pharmaceutical Technology

NOVEMBER 22, 2022

An imbalance between supply and demand of plasmid DNA — a key raw material in mRNA production — has also become a bottleneck. . The Figurate automation platform provides a central data repository, enabling process analytics, reporting, and regulatory compliance.

Manufacturing 130

Manufacturing Vaccination Vaccine RNA 130

FDA Law Blog

JANUARY 5, 2023

Claud — As we turn into the New Year, we offer a few items of interest in digital and telehealth regulation, enforcement, and compliance that may provide some helpful guideposts for stakeholders. By John W.M. Digital providers and manufacturers not only have the concerns of the FDA to consider, but those of the FTC as well.

Regulation 59

Regulation Production Drug Delivery Insulin 59

Drug Discovery World

SEPTEMBER 7, 2022

Many companies have embarked on a digitalisation journey, convinced that their notebook entries, DNA and protein designs, samples used in experiments, and experimental conditions should all be tracked and stored in software. If all the work scientists do is captured in software, it ought to be easier to analyse. . User-centric is key .

Scientist 52

Scientist Life Science Antibody Protein 52

Drug Discovery World

MARCH 27, 2023

This approach supports a Five Safes framework – safe projects, safe people, safe data, safe settings, and safe outputs. Room for growth While TREs offer enormous potential, they are not yet a panacea for the complexities of DNA analysis. TREs are effectively still in their infancy and lack universal standards and guidelines.

Genome 52

Genome Genomics Research Scientist 52

The Pharma Data

AUGUST 3, 2021

For additional information about the factors that could cause actual results to differ materially from forward-looking statements, please see the company’s latest Form 10-K and subsequent Forms 8-K and 10-Q filed with the SEC.

Antibody 52

Antibody Sales Production Development 52

Advarra

JUNE 12, 2023

IRB IBC Required when: Research involves human subjects Research involves gene therapy or genetic engineering of the treatments (e.g.,

Genetic Engineering 98

Genetic Engineering Gene Therapy Genetics Engineer 98

Drug Discovery World

JUNE 6, 2023

The only way we’re going to do that was improved diagnostic techniques.” At the meeting, Jordan says we are seeing improvements in circulating tumour DNA, circulating tumour cell diagnosis, as well as ways of detecting tumours before they are detectable through standard methodologies, such as CT scans. It’s a 1.5

Protein 52

Protein DNA RNA Research 52

Roots Analysis

OCTOBER 16, 2023

Applications of Biopharma Filtration Biopharmaceutical filtration is critical process used in manufacture of biological products such as, antibodies, vaccines, virus removal, blood plasma fractionation , cell culture clarification, cell harvesting, recombinant proteins, DNA and RNA.

Bacteria 40

Bacteria Production Contamination Protein 40

Drug Discovery World

FEBRUARY 27, 2023

More so, controlled access and traceability supports regulatory compliance and its size and design enable its use for researchers within the lab. The technology offers features for cell and gene therapy developers and manufacturers, such as end stage deployment at the clinic or hospital.

Drugs 52

Drugs Life Science Protein Scientist 52

Pharmaceutical Technology

FEBRUARY 20, 2023

This white paper explores the roles immunohistochemistry (IHC), next-generation sequencing (NGS), and circulating tumour DNA (ctDNA) play in non-small cell lung cancer (NSCLC) precision medicine therapy development, and how they help healthcare providers determine the most effective treatment regimens for their patients.

Research 130

Research Clinical Trials Clinical Trials Clinical Research 130